| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 9 |
| 1 | LETROZOLE TABLETS | 9 |
| 2 | RIBOCICLIB | 9 |
| 3 | TACROLIMUS | 9 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 9 |
| 5 | TACROLIMUS OINTMENT 0.1% | 9 |
| 6 | INFLIXIMAB | 8 |
| 7 | FULVESTRANT | 7 |
| 8 | MYCOPHENOLATE MOFETIL | 6 |
| 9 | ALBENDAZOLE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEBENDAZOLE | 2 | 0.0025 |
| 1 | ALBENDAZOLE | 3 | 0.0016 |
| 2 | CEFUROXIME SODIUM | 1 | 0.0008 |
| 3 | PYRIMETHAMINE | 1 | 0.0008 |
| 4 | BARICITINIB | 1 | 0.0003 |
| 5 | RIBOCICLIB | 9 | 0.0003 |
| 6 | FULVESTRANT | 7 | 0.0002 |
| 7 | LOTEPREDNOL ETABONATE | 1 | 0.0002 |
| 8 | LETROZOLE TABLETS | 9 | 0.0002 |
| 9 | SIROLIMUS | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 3 | 0.0010 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 2 | Estrogen Receptor Antagonist [EPC] | 7 | 0.0002 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 4 | Aromatase Inhibitor [EPC] | 9 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |